Wuhan Ruijiakang Biotechnology Co., Ltd. announced that it has raised CNY 20 million in a round of funding on August 21, 2023. The transaction included participation from new investors, Anhui Huaheng Biotechnology Co., Ltd. and Suzhou Kaifeng Zhengde Investment Management Co., Ltd.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
119.3 CNY | +0.40% | -2.71% | -5.27% |
04-22 | Anhui Huaheng Biotechnology's Q1 Profit Jumps 7% | MT |
04-22 | Anhui Huaheng Biotechnology's 2023 Profit Jumps 40% | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.27% | 2.58B | |
+0.92% | 29.67B | |
+19.34% | 24.65B | |
+6.15% | 11.06B | |
+16.80% | 5.37B | |
+20.52% | 4.52B | |
-5.20% | 3.86B | |
+1.90% | 3.4B | |
+1.25% | 3.02B | |
+26.46% | 2.84B |
- Stock Market
- Equities
- 688639 Stock
- News Anhui Huaheng Biotechnology Co., Ltd.
- Wuhan Ruijiakang Biotechnology Co., Ltd. announced that it has received CNY 20 million in funding from Anhui Huaheng Biotechnology Co., Ltd., Suzhou Kaifeng Zhengde Investment Management Co., Ltd.